The Asia Pacific Artificial Intelligence in Diagnostics Market would witness market growth of 22.4% CAGR during the forecast period (2024-2031).
The China market dominated the Asia Pacific Other Diagnosis Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $39.4 million by 2031. The Japan market is registering a CAGR of 24.3% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 26.1% during (2024 - 2031).
Governments and regulatory bodies support AI adoption in healthcare by approving AI-driven diagnostic tools and establishing guidelines for their safe use. AI-driven diagnostics are integrated with EHRs to improve data accessibility, streamline workflows, and enhance clinical decision-making. AI enables remote diagnostics, allowing healthcare providers to reach patients in rural and underserved areas. AI-powered diagnostic apps and wearable devices facilitate virtual consultations and remote monitoring.
Moreover, the use of AI in diagnostics extends beyond disease detection, encompassing a wide range of applications that enhance healthcare delivery. AI automates the analysis of medical images, reducing human error and improving diagnostic accuracy. AI models predict disease risks based on patient history, lifestyle, and genetic data, enabling early intervention and preventive care. AI-driven diagnostics support precision medicine by tailoring treatment plans based on a patient’s unique characteristics.
In India, the hospital sector was valued at INR 7,940.87 billion in FY21 and is expected to more than double by FY27, reaching INR 18,348.78 billion. The diagnostics sector, currently worth $4 billion, is also evolving rapidly, with organized players holding 25% of the market. The growing healthcare infrastructure, rising investments, and increasing adoption of AI-driven laboratory and radiology solutions are key drivers. AI-powered diagnostics will enhance efficiency in imaging, automate pathology processes, and support precision medicine, catering to India’s large and diverse patient population. The expansion of the organized diagnostics sector will further facilitate the integration of AI technologies to improve accuracy, reduce turnaround time, and support remote diagnostics in rural areas.
Free Valuable Insights: The Global Artificial Intelligence in Diagnostics Market is Predict to reach USD 5.80 Billion by 2031, at a CAGR of 21.3%
Based on Component, the market is segmented into Software, Hardware, and Services. Based on Diagnosis, the market is segmented into Neurology, Radiology, Chest & Lung, Oncology, Cardiology, Pathology, and Other Diagnosis. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.
By Component
By Diagnosis
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 